Introduction to Alvotech’s Presentation During the Morgan Stanley 23rd Annual Global Healthcare Conference, Alvotech (ALVO) presented key updates that highlighted its strategic direction and innovative approaches in the biopharmaceutical industry. Co-head of the European Pharmaceutical Equity Research, Thibault Boutherin, led the discussion, emphasizing the company’s commitment to developing high-quality biosimilars. Company Overview Alvotech specializes in…